Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.17 USD | +4.70% | +12.02% | -10.53% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.53% | 2.61B | |
+5.02% | 109B | |
+11.22% | 105B | |
-0.38% | 22.25B | |
-12.26% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.55% | 16.85B | |
+4.48% | 13.76B | |
+34.69% | 12.46B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Transcript : Denali Therapeutics Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 11